Kingdom Therapeutics
PrivateLast Round
VC Round
Jan 29, 2025
Total Funding Raised
$302,000
Company Overview
Kingdom Therapeutics is a biotechnology company that develops cannabinoid-based therapeutics targeting the gut-brain-endocannabinoid axis to treat autism spectrum disorder and other neurodevelopmental conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kingdom Therapeutics Comparables
Compare Kingdom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yamo Pharmaceuticals | 83% | |
| DeFloria, Inc. | 82% | |
| Zelira Therapeutics Ltd | 78% |
Kingdom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 29, 2025 | ||||
| Follow-on Offering | May 1, 2022 |
Kingdom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 5 Horizons Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 43% MoM, from 696 to 994.
- Jan 26, 2026
Monthly visitors increased 164% MoM.
Kingdom Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kingdom Therapeutics's valuation, stock price, and market status.
Is Kingdom Therapeutics a public or private company?
Kingdom Therapeutics is a private company.
What is the current stock price of Kingdom Therapeutics?
Kingdom Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kingdom Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kingdom Therapeutics worth (valuation)?
Valuation information for Kingdom Therapeutics is not publicly available.
Can I buy Kingdom Therapeutics stock?
Kingdom Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kingdom Therapeutics's last funding round?
Kingdom Therapeutics's most recent funding round was VC Round on January 29, 2025.
Who are the main investors in Kingdom Therapeutics?
Key investors in Kingdom Therapeutics include 5 Horizons Ventures.
Will Kingdom Therapeutics IPO soon?
No public IPO plans have been announced for Kingdom Therapeutics.
How can I track Kingdom Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kingdom Therapeutics's shares on secondary markets.